LIFE Description — aTyr Pharma Inc
aTyr Pharma is engaged in the discovery and clinical development of innovative medicines for patients suffering from severe, rare diseases. Co. has discovered approximately 300 Physiocrines (physio for life and crine for specific activity), a class of naturally occurring proteins that promotes homeostasis, a fundamental process of restoring stressed or diseased tissue to a healthier state. Co. has successfully completed a Phase 1 clinical trial of Resolaris, its first development candidate. Resolaris is used in adult patients with facioscapulohumeral muscular dystrophy, or FSHD, a severe, rare genetic myopathy with an immune component.